Drug intelligence / Profile preview

Jiere Zhike Granules

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Jiere Zhike Granules is a traditional Chinese medicine (TCM) formula developed for the treatment of post-infection cough. It is administered in granule form and evaluated for efficacy and safety in clinical trials, particularly targeting cough that persists after respiratory infections. The formulation likely contains a combination of herbal ingredients commonly used in TCM to relieve cough, clear heat from the lungs, and reduce phlegm, though specific ingredient details are not provided in the available sources. Its mechanism of action is based on traditional principles such as clearing lung heat and resolving phlegm rather than targeting specific molecular pathways[1].

Brand names: Jiere Zhike Granules
Other names: Jiere Zhike

Beyond the preview

Go deeper on Jiere Zhike Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiere Zhike Granules.

Explore the full profile